Product NDC: | 55566-5030 |
Proprietary Name: | Desmopressin Acetate |
Non Proprietary Name: | desmopressin acetate |
Active Ingredient(s): | 4 ug/mL & nbsp; desmopressin acetate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55566-5030 |
Labeler Name: | Ferring Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018938 |
Marketing Category: | NDA |
Start Marketing Date: | 19991026 |
Package NDC: | 55566-5030-1 |
Package Description: | 10 AMPULE in 1 CARTON (55566-5030-1) > 1 mL in 1 AMPULE (55566-5030-0) |
NDC Code | 55566-5030-1 |
Proprietary Name | Desmopressin Acetate |
Package Description | 10 AMPULE in 1 CARTON (55566-5030-1) > 1 mL in 1 AMPULE (55566-5030-0) |
Product NDC | 55566-5030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | desmopressin acetate |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19991026 |
Marketing Category Name | NDA |
Labeler Name | Ferring Pharmaceuticals Inc. |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | 4 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |